10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
Main contractors often make claims against subcontractors for liquidated damages for delay. A questi...
Read More >
Beginning on February 27, 2020, transactions valued at more than $94 million may require filing with...
Read More >
On October 30, 2019, the Safe Time Leave Law (“Law”) in New York’s Westchester County went into e...
Read More >
Many California laws seek to restrict the terms and conditions an employer may place on an employee ...
Read More >
There is rightfully a lot of buzz in the industry about force majeure clauses. Authors are writing ...
Read More >
The National Labor Relations Board recently released a Decision and Order finding that a financial s...
Read More >